During the federal regulatory review and approval process, AHI provides suggested guidance – or “points to consider” – for company sponsors who are preparing study protocols for new medicines under review with the FDA’s Center for Veterinary Medicine.
CVM Helpful Hints for Labeling Submissions
September 22, 2009
Data Submissions for the CVM ONADE Primary Review Divisions
September 24, 2007